Evidence map›Paper›PMID 16278677›Full record

ArticleOncogene2006

Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.

C S Hayes, K DeFeo, L Lan, B Paul, C Sell, S K Gilmour

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Polyamines and nonmelanoma skin cancer.Toxicology and applied pharmacology · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

C S HayesLankenau Institute for Medical Research, Wynnewood, PA 19096, USA.
K DeFeo
L Lan
B Paul
C Sell
S K Gilmour
Lankenau Institute for Medical Research · US

Funding

POLYAMINES AND EPITHELIAL TUMORIGENESISR01CA070739 · NCI · LANKENAU INSTITUTE FOR MEDICAL RESEARCH · PI GILMOUR, SUSAN K. · 1996 to 2010
$2.8M
NCI NIH HHS CA070739
6 · The paper itself

Abstract

Ornithine decarboxylase (ODC) overexpression coupled with activated Ras is fully sufficient to oncogenically transform primary keratinocytes. To determine the Ras effector pathways that represent the minimal essential contribution to full oncogenic transformation in this context, we evaluated the cooperativity of different Ras effector mutants with overexpressed ODC in an in vivo tracheal xenotransplantation assay for epithelial cell invasiveness. Primary keratinocytes, isolated from either K6/ODC transgenic mouse skin (expressing increased ODC) or from normal littermate skin were infected with retrovirus producing an activated RasV12 or partial loss-of-function effector mutants of RasV12 that selectively induce only the Raf/ERK, RalGDS, or the PI3-kinase signaling pathway. Whereas keratinocytes expressing a fully activated RasV12 are not invasive in tracheal xenotransplants, ODC-overexpressing keratinocytes acquire an invasive phenotype with additional expression of either RasV12 or activation of the Raf/ERK pathway. Independent of a mutated ras, elevated levels of ODC activate the Akt/mTOR signaling pathway as well as the Rho/Rac pathway in primary keratinocytes. Thus, Raf/ERK signaling is sufficient to cooperate with increased ODC activity in the conversion of normal keratinocytes to invasive cells. In order to promote invasiveness in keratinocytes, elevated levels of ODC may cooperate with Raf/ERK via activation of the Akt and Rho/Rac signaling pathway.

Indexed as

AnimalsCells, CulturedCell Transformation, NeoplasticEnzyme ActivationExtracellular Signal-Regulated MAP KinasesKeratinocytesMiceMice, Inbred C57BLMice, TransgenicNeoplasm InvasivenessNIH 3T3 CellsOrnithine DecarboxylasePhosphatidylinositol 3-KinasesPolyaminesProto-Oncogene Proteins c-aktrac GTP-Binding ProteinsExtracellular Signal-Regulated MAP KinasesOrnithine DecarboxylasePhosphatidylinositol 3-KinasesPolyaminesProto-Oncogene Proteins c-aktrac GTP-Binding Proteinsraf Kinasesral Guanine Nucleotide Exchange Factorrho GTP-Binding Proteins

Identifiers

PMID16278677
OpenAlexW2039911500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.